PMID- 8159738 OWN - NLM STAT- MEDLINE DCOM- 19940516 LR - 20190501 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 91 IP - 8 DP - 1994 Apr 12 TI - Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. PG - 3275-9 AB - The Cl- secretory pathway that is defective in cystic fibrosis (CF) can be bypassed by an alternative pathway for Cl- transport that is activated by extracellular nucleotides. Accordingly, the P2 receptor that mediates this effect is a therapeutic target for improving Cl- secretion in CF patients. In this paper, we report the sequence and functional expression of a cDNA cloned from human airway epithelial (CF/T43) cells that encodes a protein with properties of a P2U nucleotide receptor. With a retrovirus system, the human airway clone was stably expressed in 1321N1 astrocytoma cells, a human cell line unresponsive to extracellular nucleotides. Studies of inositol phosphate accumulation and intracellular Ca2+ mobilization induced by extracellular nucleotides in 1321N1 cells expressing the receptor identified this clone as the target receptor in human airway epithelia. In addition, we independently isolated an identical cDNA from human colonic epithelial (HT-29) cells, indicating that this is the same P2U receptor that has been functionally identified in other human tissues. Expression of the human P2U receptor (HP2U) in 1321N1 cells revealed evidence for autocrine ATP release and stimulation of transduced receptors. Thus, HP2U expression in the 1321N1 cell line will be useful for studying autocrine regulatory mechanisms and in screening of potential therapeutic drugs. FAU - Parr, C E AU - Parr CE AD - Division of Pulmonary Diseases, University of North Carolina, Chapel Hill 27599-7020. FAU - Sullivan, D M AU - Sullivan DM FAU - Paradiso, A M AU - Paradiso AM FAU - Lazarowski, E R AU - Lazarowski ER FAU - Burch, L H AU - Burch LH FAU - Olsen, J C AU - Olsen JC FAU - Erb, L AU - Erb L FAU - Weisman, G A AU - Weisman GA FAU - Boucher, R C AU - Boucher RC FAU - Turner, J T AU - Turner JT LA - eng SI - GENBANK/U07225 GR - DE07389/DE/NIDCR NIH HHS/United States GR - GM36887/GM/NIGMS NIH HHS/United States GR - HL34322/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Chloride Channels) RN - 0 (DNA Primers) RN - 0 (DNA, Complementary) RN - 0 (Inositol Phosphates) RN - 0 (P2RY2 protein, human) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Cell Surface) RN - 0 (Receptors, Purinergic P2) RN - 0 (Receptors, Purinergic P2Y2) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - 8Y164V895Y (Carbachol) RN - SY7Q814VUP (Calcium) RN - UT0S826Z60 (Uridine Triphosphate) SB - IM EIN - Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):13067. PMID: 7809171 MH - Adenosine Triphosphate/pharmacology MH - Amino Acid Sequence MH - Base Sequence MH - Calcium/metabolism MH - Carbachol/pharmacology MH - Chloride Channels/*genetics MH - Cloning, Molecular MH - DNA Primers/chemistry MH - DNA, Complementary/genetics MH - Gene Expression MH - Genes MH - Humans MH - Inositol Phosphates/metabolism MH - Molecular Sequence Data MH - RNA, Messenger/genetics MH - Receptors, Cell Surface/*genetics MH - Receptors, Purinergic P2/*genetics/metabolism MH - Receptors, Purinergic P2Y2 MH - Signal Transduction MH - Tissue Distribution MH - Uridine Triphosphate/pharmacology PMC - PMC43559 EDAT- 1994/04/12 00:00 MHDA- 1994/04/12 00:01 PMCR- 1994/10/12 CRDT- 1994/04/12 00:00 PHST- 1994/04/12 00:00 [pubmed] PHST- 1994/04/12 00:01 [medline] PHST- 1994/04/12 00:00 [entrez] PHST- 1994/10/12 00:00 [pmc-release] AID - 10.1073/pnas.91.8.3275 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3275-9. doi: 10.1073/pnas.91.8.3275.